2018 Reimbursement Cuts for Some Off-Campus Hospital Provider-Based Departments

by McGuireWoods LLP
Contact

On Nov. 2, 2017, the Centers for Medicare and Medicaid Services (CMS) finalized a rule changing reimbursement rates under the Medicare Physician Fee Schedule (MPFS) for certain non-excepted hospital off-campus provider-based departments (PBDs). These off-campus PBDs will see their payments cut by 20 percent beginning Jan. 1, 2018, meaning they will receive only 40 percent of the applicable outpatient prospective payment system (OPPS) rate, as opposed to the 50 percent they receive this year. To prepare non-excepted PBDs for these reimbursement changes, this legal alert outlines the key reimbursement changes established by the CY 2018 final rule.

As discussed in a Jan.18, 2017, McGuireWoods legal alert, Reimbursement Changes for Hospital Off-Campus Provider-Based Departments, CMS this year implemented Section 603 of the Bipartisan Budget Act of 2015’s “site-neutral” payment policies for newly acquired, developed or relocated PBDs. As a result, only excepted off-campus PBDs — such as those facilities that billed as PBDs prior to Nov. 2, 2015 — continue to be paid under the OPPS. Non-excepted PBDs are now reimbursed under the MPFS, which reimburses PBDs based on a “relativity adjuster” to the OPPS rate. Currently, non-excepted PBDs receive approximately 50 percent of the OPPS rates for non-excepted items and services; however, as discussed in a Sept. 1, 2017, McGuireWoods legal alert, “CMS Proposes Reimbursement Cuts for Certain Hospital Provider-Based Departments,” CMS’s 2017 interim final rule proposed slashing the relativity adjuster in half, to 25 percent — a proposal that would have greatly impacted reimbursement for non-excepted PBDs. 

In the CY 2018 final rule, CMS slightly backed away from its proposal and instead finalized a 20 percent reduction to the current MPFS payment rates. Accordingly, non-excepted PBDs will be reimbursed at 40 percent of the OPPS beginning Jan. 1, 2018, as opposed to the current relativity adjuster of 50 percent. CMS explained that this reduction more closely reflects its estimate that the average payment difference for the top 22 codes paid in a PBD (including the most commonly billed code, which was not included in the calculations developing the CY 2017 rates: an outpatient clinic visit) averages 35 percent of OPPS rate payment. CMS hopes this adjustment will provide a more level playing field for competition between hospitals and physician practices by promoting greater alignment in payment. Nevertheless, CMS notes that this new payment rate is likely transitory, in place only until CMS has an opportunity to analyze CY 2017 claims data. 

In arriving at this new OPPS relativity adjuster for 2018, CMS compared the OPPS rate to the difference under the MPFS between the non-facility and facility rates. While noting that not all billed codes have both facility and non-facility rates (hence, the need for a relativity adjuster), CMS rejected comments that the comparison should be the full non-facility rate instead of the difference. CMS maintained that its approach better approximates the technical component to be paid to the PBD, whereas the physician bills for the professional component (which is theoretically removed when taking the difference). CMS also continued its policy of excluding certain OPPS payment adjustments (such as outlier payments, rural sole community hospital payments, cancer hospital adjustments and quality reporting payment adjustments) in the MPFS rate for PBDs

Given the temporary nature of this change to reimbursement rates under the MPFS, non-excepted PBDs should expect even more changes to reimbursement in the not-so-distant future. Further, CMS noted in response to comments that it did not have authority to develop or implement modified payment rates to further reduce payment differentials. Such commenters may turn to Congress for further site neutrality reimbursement changes.

Anecdotally, McGuireWoods lawyers have seen fewer hospital-physician group acquisitions followed by PBD conversions. This seems to indicate that the congressional intent to eliminate the Medicare payment incentive for such conversions is working. This additional 20 percent cut, as well as corresponding changes in 340B pharmaceutical reimbursement, will likely further reduce such acquisitions. Hospitals and physician groups will continue considering reimbursement changes in structuring future transactions.

In addition, hospitals have had to be careful in relocating or expanding offerings at existing PBDs.  As mentioned above, PBDs that billed under the OPPS prior to enactment of the Bipartisan Budget Act of 2015 are excepted and allowed to bill under the OPPS. CMS has taken the position that relocation of such facilities (even to a new suite in the same building) will mean they lose their grandfathered status and must be paid similarly to the non-excepted PBDs discussed herein. Only if there are “extraordinary circumstances” — such as natural disasters, significant seismic building code requirements, or significant public health and safety issues — will a CMS regional office approve relocation. CMS declined to further discuss or refine its position in the CY 2018 final rule.


The CY 2018 final rule is one of several rules reflecting CMS’ stated strategy to create better accessibility, quality, affordability, empowerment and innovation in healthcare, and it will take effect January 1, 2018. Although the explanation above details the major proposed reimbursement change under the MPFS for non-excepted PBDs, the CY 2018 final rule also contains changes and policies related to the expansion of telehealth-eligible services, modifications to the Medicare Shared Savings Program and Physician Quality Reporting, and implementation of the new Medicare Diabetes Prevention Program, among others. Accordingly, hospitals and non-hospital providers should closely examine and review the CY 2018 final rule to understand the nature of such changes.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McGuireWoods LLP | Attorney Advertising

Written by:

McGuireWoods LLP
Contact
more
less

McGuireWoods LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.